These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7835954)
1. The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. Rigas B; Tsioulias GJ; Allan C; Wali RK; Brasitus TA Immunology; 1994 Oct; 83(2):319-23. PubMed ID: 7835954 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta. Wali RK; Frawley BP; Hartmann S; Roy HK; Khare S; Scaglione-Sewell BA; Earnest DL; Sitrin MD; Brasitus TA; Bissonnette M Cancer Res; 1995 Nov; 55(22):5257-64. PubMed ID: 7585585 [TBL] [Abstract][Full Text] [Related]
4. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Singh J; Kulkarni N; Kelloff G; Reddy BS Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306 [TBL] [Abstract][Full Text] [Related]
5. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Reddy BS; Simi B; Patel N; Aliaga C; Rao CV Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306 [TBL] [Abstract][Full Text] [Related]
6. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Femia AP; Dolara P; Caderni G Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897 [TBL] [Abstract][Full Text] [Related]
7. Intermediate biomarkers of colon cancer: modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Singh J; Kelloff G; Reddy BS Carcinogenesis; 1993 Apr; 14(4):699-704. PubMed ID: 8472334 [TBL] [Abstract][Full Text] [Related]
8. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Reddy BS; Maruyama H; Kelloff G Cancer Res; 1987 Oct; 47(20):5340-6. PubMed ID: 3652039 [TBL] [Abstract][Full Text] [Related]
9. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Singh J; Kelloff G; Reddy BS Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473 [TBL] [Abstract][Full Text] [Related]
10. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+. Momen MA; Monden Y; Houchi H; Umemoto A J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Reddy BS; Tokumo K; Kulkarni N; Aligia C; Kelloff G Carcinogenesis; 1992 Jun; 13(6):1019-23. PubMed ID: 1600605 [TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708 [TBL] [Abstract][Full Text] [Related]
14. Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. Reddy BS; Tanaka T; Simi B J Natl Cancer Inst; 1985 Oct; 75(4):791-8. PubMed ID: 3862909 [TBL] [Abstract][Full Text] [Related]
15. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon. Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165 [TBL] [Abstract][Full Text] [Related]
16. Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. Seraj MJ; Umemoto A; Kajikawa A; Mimura S; Kinouchi T; Ohnishi Y; Monden Y Cancer Lett; 1997 May; 115(1):97-103. PubMed ID: 9097984 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401 [TBL] [Abstract][Full Text] [Related]
19. Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis. Kulkarni N; Zang E; Kelloff G; Reddy BS Carcinogenesis; 1992 Jun; 13(6):995-1000. PubMed ID: 1600622 [TBL] [Abstract][Full Text] [Related]
20. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Singh J; Hamid R; Reddy BS Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]